Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	SP1 ZNF765 SP2 ZNF845 ZNF140 ZNF143 ZNF527 ZNF586 ZBTB17 ZNF154 ZFP3 ZNF658 ZNF460 ZNF177 BACH2 ZNF189 ZNF112 BCL6 ZNF658B HESX1 ZNF829 ZNF551 ZNF836 ZNF497 ZSCAN30 ZNF735 NHLH1 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZFP62 ARGFX ZNF354A ZNF555 ZNF596 ZNF722 ZNF343 ISX ZFP14 TEAD1 ZNF865 YY1 ZNF850 ZNF251 DMBX1 ZNF529 ZNF879 ZNF835 ZNF2 ZNF557 ZNF419 LHX1 MLXIPL ZNF668 ZNF630 ZSCAN20 ZNF35 ATOH8 ZNF540 ZNF256 ZNF566 ZNF611 SP9 ZNF561 ZNF420 ZNF396 ZNF853 ZNF454 PRDM14	3.07e-24	1459	249	71	GO:0000977
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	SP1 ZNF765 SP2 ZNF845 ZNF140 ZNF143 ZNF527 ZNF586 ZBTB17 ZNF154 ZFP3 ZNF658 ZNF460 ZNF177 BACH2 ZNF189 ZNF112 BCL6 ZNF658B HESX1 ZNF829 ZNF551 ZNF836 ZSCAN30 ZNF735 NHLH1 ZNF534 ZNF479 ZNF616 ZNF606 ZFP62 ARGFX ZNF354A ZNF555 ZNF596 ZNF722 ZNF343 ISX ZFP14 TEAD1 YY1 ZNF850 ZNF251 DMBX1 ZNF529 ZNF879 ZNF2 ZNF557 ZNF419 LHX1 MLXIPL ZNF668 ZNF630 ZSCAN20 ZNF35 ATOH8 ZNF540 ZNF256 ZNF566 ZNF611 SP9 ZNF561 ZNF420 ZNF396 ZNF853 ZNF454	1.74e-21	1412	249	66	GO:0000981
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SP1 ZNF765 SP2 ZNF845 ZNF140 ZNF143 ZNF527 ZNF586 ZBTB17 ZNF154 ZFP3 ZNF658 ZNF460 BACH2 ZNF189 ZNF112 BCL6 ZNF658B HESX1 ZNF829 ZNF551 ZNF836 ZNF497 ZSCAN30 ZNF735 NHLH1 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZFP62 ARGFX ZNF354A ZNF722 ZFP14 TEAD1 ZNF865 YY1 ZNF850 ZNF251 ZNF879 ZNF835 ZNF2 ZNF419 LHX1 MLXIPL ZNF668 ZNF630 ZSCAN20 MTOR ATOH8 ZNF540 ZNF256 ZNF611 SP9 ZNF561 ZNF420 ZNF396 ZNF853 ZNF454	2.31e-20	1271	249	61	GO:0000987
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SP1 ZNF765 SP2 ZNF845 ZNF140 ZNF143 ZNF527 ZNF586 ZBTB17 ZNF154 ZFP3 ZNF658 ZNF460 BACH2 ZNF189 ZNF112 BCL6 ZNF658B HESX1 ZNF829 ZNF551 ZNF836 ZNF497 ZSCAN30 ZNF735 NHLH1 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZFP62 ARGFX ZNF354A ZNF722 ZFP14 TEAD1 ZNF865 YY1 ZNF850 ZNF251 ZNF879 ZNF835 ZNF2 ZNF419 MLXIPL ZNF668 ZNF630 ZSCAN20 ATOH8 ZNF540 ZNF256 ZNF611 SP9 ZNF561 ZNF420 ZNF396 ZNF853 ZNF454	1.98e-19	1244	249	59	GO:0000978
Domain	zf-C2H2	SP1 ZNF765 BNC2 SP2 ZNF845 ZNF140 ZNF143 ZNF527 ZNF586 ZBTB17 ZNF154 ZNF155 ZFP3 ZNF658 ZNF460 ZNF177 ZNF189 ZNF112 BCL6 ZNF829 ZNF551 ZNF836 ZNF497 ZSCAN30 ZNF735 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZFP62 ZNF354A ZNF555 ZNF596 ZNF343 ZFP14 ZNF865 YY1 ZNF850 ZNF251 ZNF529 ZNF879 ZNF835 ZNF2 ZNF557 ZNF419 ZNF668 ZNF630 ZSCAN20 ZNF35 ZNF540 ZNF256 ZNF566 ZNF611 SP9 ZNF561 ZNF420 ZNF396 ZNF853 ZNF454 PRDM14	1.06e-33	693	242	61	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	SP1 ZNF765 SP2 ZNF845 ZNF140 ZNF143 ZNF527 ZNF586 ZBTB17 ZNF154 ZNF155 ZFP3 ZNF658 ZNF460 ZNF177 ZNF189 ZNF112 BCL6 ZNF829 ZNF551 ZNF836 ZNF497 ZSCAN30 ZNF735 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZFP62 ZNF354A ZNF555 ZNF596 ZNF343 ZFP14 ZNF865 YY1 ZNF850 ZNF251 ZNF529 ZNF879 ZNF835 ZNF2 ZNF557 ZNF419 ZNF668 ZNF630 ZSCAN20 ZNF35 ZNF540 ZNF256 ZNF566 ZNF611 SP9 ZNF561 ZNF420 ZNF396 ZNF853 ZNF454 PRDM14	1.08e-32	694	242	60	IPR013087
Domain	-	SP1 ZNF765 SP2 ZNF845 ZNF140 ZNF143 ZNF527 ZNF586 ZBTB17 ZNF154 ZNF155 ZFP3 ZNF658 ZNF460 ZNF189 ZNF112 BCL6 ZNF829 ZNF551 ZNF836 ZNF497 ZSCAN30 ZNF735 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZFP62 ZNF354A ZNF555 ZNF596 ZNF343 ZFP14 ZNF865 YY1 ZNF850 ZNF251 ZNF529 ZNF879 ZNF835 ZNF2 ZNF557 ZNF419 ZNF668 ZNF630 ZSCAN20 ZNF35 ZNF540 ZNF256 ZNF566 ZNF611 SP9 ZNF561 ZNF420 ZNF396 ZNF853 ZNF454 PRDM14	3.01e-32	679	242	59	3.30.160.60
Domain	ZINC_FINGER_C2H2_2	SP1 ZNF765 BNC2 SP2 ZNF845 ZNF140 ZNF143 ZNF527 ZNF586 ZBTB17 ZNF154 ZNF155 ZFP3 ZNF658 ZNF460 ZNF177 ZNF189 ZNF112 BCL6 ZNF829 ZNF551 ZNF836 RBSN ZNF497 ZSCAN30 ZNF735 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZFP62 ZNF354A ZNF555 ZNF596 ZNF343 ZFP14 ZNF865 YY1 ZNF850 ZNF251 ZNF529 ZNF879 ZNF835 ZNF2 ZNF557 ZNF419 ZNF668 ZNF630 ZSCAN20 ZNF35 ZNF540 ZNF256 ZNF566 ZNF611 SP9 ZNF561 ZNF420 ZNF396 ZNF853 ZNF454 PRDM14	6.76e-32	775	242	62	PS50157
Domain	ZINC_FINGER_C2H2_1	SP1 ZNF765 BNC2 SP2 ZNF845 ZNF140 ZNF143 ZNF527 ZNF586 ZBTB17 ZNF154 ZNF155 ZFP3 ZNF658 ZNF460 ZNF177 ZNF189 ZNF112 BCL6 ZNF829 ZNF551 ZNF836 RBSN ZNF497 ZSCAN30 ZNF735 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZFP62 ZNF354A ZNF555 ZNF596 ZNF343 ZFP14 ZNF865 YY1 ZNF850 ZNF251 ZNF529 ZNF879 ZNF835 ZNF2 ZNF557 ZNF419 ZNF668 ZNF630 ZSCAN20 ZNF35 ZNF540 ZNF256 ZNF566 ZNF611 SP9 ZNF561 ZNF420 ZNF396 ZNF853 ZNF454 PRDM14	7.83e-32	777	242	62	PS00028
Domain	Znf_C2H2-like	SP1 ZNF765 BNC2 SP2 ZNF845 ZNF140 ZNF143 ZNF527 ZNF586 ZBTB17 ZNF154 ZNF155 ZFP3 ZNF658 ZNF460 ZNF177 ZNF189 ZNF112 BCL6 ZNF829 ZNF551 ZNF836 RBSN ZNF497 ZSCAN30 ZNF735 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZFP62 ZNF354A ZNF555 ZNF596 ZNF343 ZFP14 ZNF865 YY1 ZNF850 ZNF251 ZNF529 ZNF879 ZNF835 ZNF2 ZNF557 ZNF419 ZNF668 ZNF630 ZSCAN20 ZNF35 ZNF540 ZNF256 ZNF566 ZNF611 SP9 ZNF561 ZNF420 ZNF396 ZNF853 ZNF454 PRDM14	3.08e-31	796	242	62	IPR015880
Domain	Znf_C2H2	SP1 ZNF765 BNC2 SP2 ZNF845 ZNF140 ZNF143 ZNF527 ZNF586 ZBTB17 ZNF154 ZNF155 ZFP3 ZNF658 ZNF460 ZNF177 ZNF189 ZNF112 BCL6 ZNF829 ZNF551 ZNF836 RBSN ZNF497 ZSCAN30 ZNF735 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZFP62 ZNF354A ZNF555 ZNF596 ZNF343 ZFP14 ZNF865 YY1 ZNF850 ZNF251 ZNF529 ZNF879 ZNF835 ZNF2 ZNF557 ZNF419 ZNF668 ZNF630 ZSCAN20 ZNF35 ZNF540 ZNF256 ZNF566 ZNF611 SP9 ZNF561 ZNF420 ZNF396 ZNF853 ZNF454 PRDM14	5.82e-31	805	242	62	IPR007087
Domain	ZnF_C2H2	SP1 ZNF765 BNC2 SP2 ZNF845 ZNF140 ZNF143 ZNF527 ZNF586 ZBTB17 ZNF154 ZNF155 ZFP3 ZNF658 ZNF460 ZNF177 ZNF189 ZNF112 BCL6 ZNF829 ZNF551 ZNF836 RBSN ZNF497 ZSCAN30 ZNF735 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZFP62 ZNF354A ZNF555 ZNF596 ZNF343 ZFP14 ZNF865 YY1 ZNF850 ZNF251 ZNF529 ZNF879 ZNF835 ZNF2 ZNF557 ZNF419 ZNF668 ZNF630 ZSCAN20 ZNF35 ZNF540 ZNF256 ZNF566 ZNF611 SP9 ZNF561 ZNF420 ZNF396 ZNF853 ZNF454 PRDM14	7.18e-31	808	242	62	SM00355
Domain	KRAB	ZNF765 ZNF845 ZNF140 ZNF527 ZNF586 ZNF154 ZNF155 ZNF658 ZNF460 ZNF177 ZNF189 ZNF112 ZNF829 ZNF551 ZNF836 ZNF735 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZNF354A ZNF555 ZNF596 ZNF343 ZFP14 ZNF850 ZNF251 ZNF529 ZNF879 ZNF2 ZNF557 ZNF419 ZNF630 ZSCAN20 ZNF540 ZNF256 ZNF566 ZNF611 ZNF561 ZNF420 ZNF454	1.62e-27	369	242	42	SM00349
Domain	KRAB	ZNF765 ZNF845 ZNF140 ZNF527 ZNF586 ZNF154 ZNF155 ZNF658 ZNF460 ZNF177 ZNF189 ZNF112 ZNF829 ZNF551 ZNF836 ZNF735 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZNF354A ZNF555 ZNF596 ZNF343 ZFP14 ZNF850 ZNF251 ZNF529 ZNF879 ZNF2 ZNF557 ZNF419 ZNF630 ZSCAN20 ZNF540 ZNF256 ZNF566 ZNF611 ZNF561 ZNF420 ZNF454	1.81e-27	370	242	42	IPR001909
Domain	KRAB	ZNF765 ZNF845 ZNF140 ZNF527 ZNF586 ZNF154 ZNF155 ZNF658 ZNF460 ZNF177 ZNF189 ZNF112 ZNF829 ZNF551 ZNF836 ZNF735 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZNF354A ZNF555 ZNF596 ZNF343 ZFP14 ZNF850 ZNF251 ZNF529 ZNF879 ZNF2 ZNF557 ZNF419 ZNF630 ZNF540 ZNF256 ZNF566 ZNF611 ZNF561 ZNF420 ZNF454	5.66e-27	358	242	41	PS50805
Domain	KRAB	ZNF765 ZNF845 ZNF140 ZNF527 ZNF586 ZNF154 ZNF155 ZNF658 ZNF460 ZNF177 ZNF189 ZNF112 ZNF829 ZNF551 ZNF836 ZNF735 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZNF354A ZNF555 ZNF596 ZNF343 ZFP14 ZNF850 ZNF251 ZNF529 ZNF879 ZNF2 ZNF557 ZNF419 ZNF630 ZNF540 ZNF256 ZNF566 ZNF611 ZNF561 ZNF420 ZNF454	5.66e-27	358	242	41	PF01352
Domain	zf-C2H2_6	ZNF765 ZNF845 ZNF140 ZNF527 ZNF586 ZNF154 ZNF155 ZNF658 ZNF551 ZNF836 ZNF497 ZSCAN30 ZNF735 ZNF479 ZNF616 ZNF606 ZNF649 ZFP62 ZNF354A ZNF555 ZFP14 ZNF865 ZNF850 ZNF251 ZNF879 ZNF419 ZNF668 ZNF540 ZNF256 ZNF566 ZNF611 ZNF561 ZNF420	1.24e-20	314	242	33	PF13912
Domain	ASH	ASPM HYDIN	1.67e-04	2	242	2	IPR031549
Domain	Ribosomal_L26	RPL26 RPL26L1	1.67e-04	2	242	2	PF16906
Domain	ASH	ASPM HYDIN	1.67e-04	2	242	2	PF15780
Domain	Ribosomal_L26/L24P_euk/arc	RPL26 RPL26L1	1.67e-04	2	242	2	IPR005756
Domain	Sp1_fam	SP1 SP2 SP9	2.41e-04	10	242	3	IPR030450
Domain	DHR-1_domain	DOCK5 DOCK6 DOCK10	3.28e-04	11	242	3	IPR027007
Domain	DHR_2	DOCK5 DOCK6 DOCK10	3.28e-04	11	242	3	PS51651
Domain	DHR_1	DOCK5 DOCK6 DOCK10	3.28e-04	11	242	3	PS51650
Domain	DHR-2	DOCK5 DOCK6 DOCK10	3.28e-04	11	242	3	PF06920
Domain	DOCK	DOCK5 DOCK6 DOCK10	3.28e-04	11	242	3	IPR026791
Domain	DOCK_C	DOCK5 DOCK6 DOCK10	3.28e-04	11	242	3	IPR010703
Domain	DOCK-C2	DOCK5 DOCK6 DOCK10	3.28e-04	11	242	3	PF14429
Domain	DHR-2	DOCK5 DOCK6 DOCK10	3.28e-04	11	242	3	IPR027357
Domain	Ribosomal_L24/26_CS	RPL26 RPL26L1	4.97e-04	3	242	2	IPR005825
Domain	RIBOSOMAL_L24	RPL26 RPL26L1	4.97e-04	3	242	2	PS01108
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	SP1 ZNF140 ZNF143 ZNF586 ZNF154 ZNF155 ZNF658 ZNF460 ZNF189 ZNF112 BCL6 ZNF551 H2BC1 KMT2C ZNF735 MLH1 ZNF479 ZNF616 ZNF606 MED17 ZNF649 FYTTD1 ZNF354A ZNF555 ZNF596 COX7A2 ZNF343 ZFP14 TEAD1 ATAD2 YY1 ZNF529 ZNF2 ZNF557 ZNF419 ZNF668 MTOR ZNF540 ZNF256 ZNF566 ZNF611 SMARCE1 ZNF561 ZNF420 ZNF454	4.01e-09	1387	182	45	M734
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	SP1 SP2 ZNF140 ZNF460 ZNF177 BACH2 BCL6 HESX1 NHLH1 ARGFX ZNF343 ISX TEAD1 YY1 DMBX1 LHX1 SP9 ZNF396 ZNF454	1.90e-08	544	250	19	28473536
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ZNF765 ZNF845 ZNF143 ZNF658 LEMD3 ZNF460 ZNF189 IRS1 SMC5 SLC30A1 SRPRB DDOST ZNF551 DLGAP3 STX3 PLEC GOLGB1 ZFP62 CHD8 YY1 ZNF850 ZNF668 TXNDC15 ASPH ZNF566 ZNF420 PRKDC HERC4	5.51e-08	1203	250	28	29180619
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF845 ZNF140 ZNF460 ZNF649 ZNF354A ZNF555 ZNF529 ZNF419 ZNF566 ZNF611 ZNF561	9.11e-08	181	250	11	37372979
Pubmed	Isolation and fine mapping of 16 novel human zinc finger-encoding cDNAs identify putative candidate genes for developmental and malignant disorders.	ZNF140 ZNF143 ZBTB17 ZNF154 ZNF155	1.06e-07	17	250	5	7557990
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	ZNF586 ZFP3 ZNF177 GPR87 RPS19 DDOST LUZP1 NCBP3 KMT2C SNX8 HELZ PLEC GOLGB1 PHTF2 LAMA4 ATAD2 LRRC8D DICER1 ZNF529 SBNO2 ZNF419 ZNF35 MTOR ZNF566 PRKCH ZNF561 BSCL2 HYDIN	2.40e-07	1293	250	28	15342556
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GPHN RPL26 DENND4A SPIRE2 CDC42EP4 MAP1B IRS1 LUZP1 WWC2 RBSN HELZ PLEC DOCK6 MAP4K4 GOLGB1 KIF23 IRS4 MLXIPL C2CD3 MTOR MUSK DOP1A	3.39e-07	861	250	22	36931259
Pubmed	Motor dysfunction in type 5 adenylyl cyclase-null mice.	ADCY5 DRD1 DRD2	3.67e-07	3	250	3	12665504
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SP1 BNC2 SP2 ZNF143 ZBTB17 BACH2 KDM5D HESX1 PHF1 ZNF836 ZNF616 TEAD1 ATAD2 YY1 DMBX1 ZNF2 ZNF419 ZNF668 ZSCAN20 ZNF566 SMARCE1	4.82e-07	808	250	21	20412781
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SPIRE2 C15orf39 IRS1 SFI1 PPP1R26 KMT2C PTPRS KCNJ11 PKD1 SNX8 PLEC HERC1 DOCK6 IQCE RTL6 SZT2 CTC1 CHD8 POM121C ZNF865 SBNO2 C2CD3 ARAP3 MTOR PRKDC	5.01e-07	1105	250	25	35748872
Pubmed	Human transcription factor protein interaction networks.	RPL26 SP1 SP2 ZNF143 C15orf39 RPS19 DDOST KMT2C NHLH1 HELZ HERC1 MED17 KIF23 IRS4 COX7A2 COP1 ISX CHD8 TEAD1 POM121C YY1 ZNF850 LHX1 RPL26L1 ZNF611 MARF1 SP9 SMARCE1 ZNF420	5.47e-07	1429	250	29	35140242
Pubmed	Regulation of embryonic kidney branching morphogenesis and glomerular development by KISS1 receptor (Gpr54) through NFAT2- and Sp1-mediated Bmp7 expression.	SP1 BMP7 PKD1 LHX1	8.27e-07	11	250	4	20375015
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	GPHN ZNF658B H2BC1 ZNF836 ZNF616 PYGL ZNF606 ZFP62 IRS4 DOCK10 ZNF251 ZNF879 ZNF557 ZSCAN20 ZNF540	1.14e-06	451	250	15	36168627
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SART3 DENND4A ZNF143 MAP1B C15orf39 DDOST DOCK5 MLH1 HELZ MAP4K4 DOCK10 CHD8 DICER1 SBNO2 ARAP3 TRMT2A ASPH MARF1	1.34e-06	650	250	18	38777146
Pubmed	Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR.	ZNF836 ZNF616 ZFP62 ZNF850 ZNF566 ZNF420	1.40e-06	49	250	6	9630514
Pubmed	Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase.	ADCY5 DRD1 DRD2	1.46e-06	4	250	3	12223546
Pubmed	KRAB zinc-finger proteins contribute to the evolution of gene regulatory networks.	ZNF735 ZNF879 ZNF853	1.46e-06	4	250	3	28273063
Pubmed	Docking motif-guided mapping of the interactome of protein phosphatase-1.	MAP1B GRXCR1 SFI1 PPP1R26 SPOCD1 MARF1 HYDIN	1.85e-06	80	250	7	19389623
Pubmed	Cys2His2 zinc finger protein family: classification, functions, and major members.	ZNF735 ZNF879 ZNF853	7.22e-06	6	250	3	22803940
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RPL26 SP1 SP2 ZNF845 ZBTB17 LEMD3 RPS19 SRPRB DDOST DOCK5 KMT2C ZSCAN30 MED17 HNRNPDL KIF23 FYTTD1 TEAD1 PRC1 POM121C YY1 MLXIPL ZNF668 ASPH SMARCE1 PRKDC	8.13e-06	1294	250	25	30804502
Pubmed	A census of human transcription factors: function, expression and evolution.	SP1 SP2 ZNF143 ZBTB17 BACH2 BCL6 HESX1 ZNF551 NHLH1 ARGFX ISX TEAD1 YY1 DMBX1 MLXIPL ZSCAN20 ZNF35 ATOH8 SP9 ZNF396	1.07e-05	908	250	20	19274049
Pubmed	A human MAP kinase interactome.	SP1 CDC42EP4 KMT2C HELZ PLEC MAP4K4 GOLGB1 LAMA3 LAMA4 CHD8 POM121C PRKCH PRKDC TNS1	1.32e-05	486	250	14	20936779
Pubmed	Diverse Non-genetic, Allele-Specific Expression Effects Shape Genetic Architecture at the Cellular Level in the Mammalian Brain.	MAP1B CACNG2 BMP7	2.00e-05	8	250	3	28238550
Pubmed	Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1.	ZNF460 ZNF829 ZNF649 YY1 ZNF566 SMARCE1 PRKDC	2.18e-05	116	250	7	21549307
Pubmed	The European renal genome project: an integrated approach towards understanding the genetics of kidney development and disease.	BMP7 GCLC ASPM SLC9A7 NHLH1 CASR SLC3A1 SLC9A2 ATOH8	2.51e-05	212	250	9	19521566
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	GPHN SART3 LEMD3 SRPRB DDOST LUZP1 WWC2 DLGAP3 PTPRS SNX8 HELZ PYGL CAPN2 TTC27 DICER1 ANKRD13A ARAP3 MTOR ASPH PRKDC	2.91e-05	974	250	20	28675297
Pubmed	Confirmation of quantitative trait loci for cocaine-induced activation in the AcB/BcA series of recombinant congenic strains.	CHRND DRD1 DRD2	2.99e-05	9	250	3	12777963
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	SART3 SP1 SMC5 DDOST KMT2C RBSN GCLC ASPM HELZ MAP4K4 KIF23 SZT2 COP1 CHD8 OAZ1 TEAD1 ATAD2 YY1 DICER1 MLXIPL TRMT2A CPLX3 RAB15 HECA	3.59e-05	1327	250	24	32694731
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SMC5 KMT2C SRGAP3 DOCK10 CHD8 DICER1 GRIP2 STK38L UNC80	4.00e-05	225	250	9	12168954
Pubmed	Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight.	IRS1 ADCY5 ADAMTS9 KCNJ11	4.02e-05	27	250	4	20490451
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SART3 MAP1B RPS19 SRPRB DDOST LUZP1 ASPM MLH1 PYGL DDX60L PLEC MVP HNRNPDL KIF23 PLEKHG4 CAPN2 DOCK10 TTC27 DGKD CHD8 ATAD2 ARAP3 ASPH PRKDC	4.86e-05	1353	250	24	29467282
Pubmed	Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system.	DRD1 DRD2	5.15e-05	2	250	2	11567069
Pubmed	Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair?	PKD1 MTOR	5.15e-05	2	250	2	17102641
Pubmed	When chocolate seeking becomes compulsion: gene-environment interplay.	DRD1 DRD2	5.15e-05	2	250	2	25781028
Pubmed	Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation.	DRD1 DRD2	5.15e-05	2	250	2	22100647
Pubmed	Role of silent polymorphisms within the dopamine D1 receptor associated with schizophrenia on D1-D2 receptor hetero-dimerization.	DRD1 DRD2	5.15e-05	2	250	2	20081237
Pubmed	Distinct functions of the two isoforms of dopamine D2 receptors.	DRD1 DRD2	5.15e-05	2	250	2	11089973
Pubmed	Whole-Brain Mapping of Direct Inputs to Dopamine D1 and D2 Receptor-Expressing Medium Spiny Neurons in the Posterior Dorsomedial Striatum.	DRD1 DRD2	5.15e-05	2	250	2	33380525
Pubmed	MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR.	MLXIPL MTOR	5.15e-05	2	250	2	36809979
Pubmed	Expression of the Pkd1 gene is momentously regulated by Sp1.	SP1 PKD1	5.15e-05	2	250	2	17890878
Pubmed	D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms.	DRD1 DRD2	5.15e-05	2	250	2	23680635
Pubmed	Dissociable electrophysiological subprocesses during response inhibition are differentially modulated by dopamine D1 and D2 receptors.	DRD1 DRD2	5.15e-05	2	250	2	27021648
Pubmed	Dopamine depletion results in increased neostriatal D(2), but not D(1), receptor binding in humans.	DRD1 DRD2	5.15e-05	2	250	2	11920160
Pubmed	Ventral Pallidum Is the Primary Target for Accumbens D1 Projections Driving Cocaine Seeking.	DRD1 DRD2	5.15e-05	2	250	2	30622165
Pubmed	Locomotor behavior of dopamine D1 receptor transgenic/D2 receptor deficient hybrid mice.	DRD1 DRD2	5.15e-05	2	250	2	11423089
Pubmed	Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil.	DRD1 DRD2	5.15e-05	2	250	2	18716204
Pubmed	Candidate gene study reveals DRD1 and DRD2 as putative interacting risk factors for youth depression.	DRD1 DRD2	5.15e-05	2	250	2	27472173
Pubmed	mTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress.	MLXIPL MTOR	5.15e-05	2	250	2	28606928
Pubmed	Dopamine receptor activation increases HIV entry into primary human macrophages.	DRD1 DRD2	5.15e-05	2	250	2	25268786
Pubmed	D1 and D2 dopamine receptors in separate circuits cooperate to drive associative long-term potentiation in the prefrontal cortex.	DRD1 DRD2	5.15e-05	2	250	2	20805489
Pubmed	DRD1 and DRD2 genotypes modulate processing modes of goal activation processes during action cascading.	DRD1 DRD2	5.15e-05	2	250	2	24719111
Pubmed	D1- and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro.	DRD1 DRD2	5.15e-05	2	250	2	10051231
Pubmed	Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome.	IRS1 PKD1	5.15e-05	2	250	2	27785750
Pubmed	Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions.	DRD1 DRD2	5.15e-05	2	250	2	11069937
Pubmed	Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.	IRS1 MTOR	5.15e-05	2	250	2	15604215
Pubmed	Differential roles of dopamine D1 and D2 receptor-containing neurons of the nucleus accumbens shell in behavioral sensitization.	DRD1 DRD2	5.15e-05	2	250	2	26442961
Pubmed	Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling.	GPHN MTOR	5.15e-05	2	250	2	10325225
Pubmed	Endogenous opioids mediate basal hedonic tone independent of dopamine D-1 or D-2 receptor activation.	DRD1 DRD2	5.15e-05	2	250	2	14960355
Pubmed	Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.	DRD1 DRD2	5.15e-05	2	250	2	21303698
Pubmed	Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.	DRD1 DRD2	5.15e-05	2	250	2	24322206
Pubmed	Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor.	DRD1 DRD2	5.15e-05	2	250	2	28119185
Pubmed	Role of dopamine receptors subtypes, D1-like and D2-like, within the nucleus accumbens subregions, core and shell, on memory consolidation in the one-trial inhibitory avoidance task.	DRD1 DRD2	5.15e-05	2	250	2	19117916
Pubmed	Role of dopamine D1-like receptors in methamphetamine locomotor responses of D2 receptor knockout mice.	DRD1 DRD2	5.15e-05	2	250	2	18363855
Pubmed	Molecular characterization of human tensin.	CAPN2 TNS1	5.15e-05	2	250	2	11023826
Pubmed	Accumbal dopamine D2 receptors are important for sensorimotor gating in C3H mice.	DRD1 DRD2	5.15e-05	2	250	2	17712281
Pubmed	A silent eligibility trace enables dopamine-dependent synaptic plasticity for reinforcement learning in the mouse striatum.	DRD1 DRD2	5.15e-05	2	250	2	29603470
Pubmed	Dopamine D1 and D2 receptors are distinctly associated with rest-activity rhythms and drug reward.	DRD1 DRD2	5.15e-05	2	250	2	34264865
Pubmed	The Role of DRD1 and DRD2 Receptors for Response Selection Under Varying Complexity Levels: Implications for Metacontrol Processes.	DRD1 DRD2	5.15e-05	2	250	2	31123756
Pubmed	Dopamine receptors D1 and D2 are related to observed maternal behavior.	DRD1 DRD2	5.15e-05	2	250	2	22574669
Pubmed	Predominant D1 Receptors Involvement in the Over-expression of CART Peptides after Repeated Cocaine Administration.	DRD1 DRD2	5.15e-05	2	250	2	25729269
Pubmed	Chronic haloperidol-induced spatial memory deficits accompany the upregulation of D(1) and D(2) receptors in the caudate putamen of C57BL/6 mouse.	DRD1 DRD2	5.15e-05	2	250	2	22884478
Pubmed	m-Calpain colocalizes with the calcium-sensing receptor (CaR) in caveolae in parathyroid cells and participates in degradation of the CaR.	CAPN2 CASR	5.15e-05	2	250	2	12783889
Pubmed	Complement receptor 3 deficiency influences lesion progression during Leishmania major infection in BALB/c mice.	ITGAM PRKDC	5.15e-05	2	250	2	19797068
Pubmed	Differential contributions of prefrontal and hippocampal dopamine D(1) and D(2) receptors in human cognitive functions.	DRD1 DRD2	5.15e-05	2	250	2	19005068
Pubmed	A novel nucleolar protein interacts with ribosomal protein S19.	RPS19 RPS19BP1	5.15e-05	2	250	2	16289379
Pubmed	Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.	DRD1 DRD2	5.15e-05	2	250	2	18279319
Pubmed	BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.	ZBTB17 BCL6	5.15e-05	2	250	2	16142238
Pubmed	Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia.	MTOR PRKDC	5.15e-05	2	250	2	27235137
Pubmed	Polymorphisms in dopaminergic genes predict proactive processes of response inhibition.	DRD1 DRD2	5.15e-05	2	250	2	30586202
Pubmed	TEAD1 enhances proliferation via activating SP1 in colorectal cancer.	SP1 TEAD1	5.15e-05	2	250	2	27434865
Pubmed	Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat.	SP1 PRKDC	5.15e-05	2	250	2	9525578
Pubmed	mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK.	IRS1 MTOR	5.15e-05	2	250	2	23607966
Pubmed	A novel human zinc finger protein ZNF540 interacts with MVP and inhibits transcriptional activities of the ERK signal pathway.	MVP ZNF540	5.15e-05	2	250	2	16815308
Pubmed	Season of birth and dopamine receptor gene associations with impulsivity, sensation seeking and reproductive behaviors.	DRD1 DRD2	5.15e-05	2	250	2	18030347
Pubmed	Tumor suppression and improvement in immune systems by specific activation of dopamine D1-receptor-expressing neurons in the nucleus accumbens.	DRD1 DRD2	5.15e-05	2	250	2	35172858
Pubmed	Aluminum exposure decreases dopamine D1 and D2 receptor expression in mouse brain.	DRD1 DRD2	5.15e-05	2	250	2	17984145
Pubmed	Delineation of cystinuria in Saudi Arabia: A case series.	SLC9A7 SLC3A1	5.15e-05	2	250	2	28166740
Pubmed	DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer.	MTOR PRKDC	5.15e-05	2	250	2	32209447
Pubmed	Transfer of type II collagen-induced arthritis from DBA/1 to severe combined immunodeficiency mice can be prevented by blockade of Mac-1.	ITGAM PRKDC	5.15e-05	2	250	2	8690467
Pubmed	Insulin signaling in type 2 diabetes: experimental and modeling analyses reveal mechanisms of insulin resistance in human adipocytes.	IRS1 MTOR	5.15e-05	2	250	2	23400783
Pubmed	In vivo imaging identifies temporal signature of D1 and D2 medium spiny neurons in cocaine reward.	DRD1 DRD2	5.15e-05	2	250	2	26831103
Pubmed	Enhanced latent inhibition in dopamine receptor-deficient mice is sex-specific for the D1 but not D2 receptor subtype: implications for antipsychotic drug action.	DRD1 DRD2	5.15e-05	2	250	2	19012810
Pubmed	Cloning of the LamA3 gene encoding the alpha 3 chain of the adhesive ligand epiligrin. Expression in wound repair.	LAMA3 LAMA4	5.15e-05	2	250	2	8077230
Pubmed	Cell type-specific activation of mitogen-activated protein kinase in D1 receptor-expressing neurons of the nucleus accumbens potentiates stimulus-reward learning in mice.	DRD1 DRD2	5.15e-05	2	250	2	30258218
Pubmed	Reciprocal modulation of function between the D1 and D2 dopamine receptors and the Na+,K+-ATPase.	DRD1 DRD2	5.15e-05	2	250	2	18984584
Pubmed	Distinct motor impairments of dopamine D1 and D2 receptor knockout mice revealed by three types of motor behavior.	DRD1 DRD2	5.15e-05	2	250	2	25076876
Pubmed	Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation.	BACH2 BCL6	5.15e-05	2	250	2	24277074
Pubmed	Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice.	DRD1 DRD2	5.15e-05	2	250	2	15272078
Pubmed	The role of dopamine receptors in regulating the size of axonal arbors.	DRD1 DRD2	5.15e-05	2	250	2	11438590
Pubmed	Patterns of cyclic AMP formation by coexpressed D1 and D2L dopamine receptors in HEK 293 cells.	DRD1 DRD2	5.15e-05	2	250	2	11918350
Pubmed	Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice.	DRD1 DRD2	5.15e-05	2	250	2	19274089
Interaction	NOTCH2 interactions	SP1 ZNF765 SP2 ZBTB17 ZNF460 ZNF189 MFNG ZNF497 ADAMTS9 ZNF649 ZNF555 CASR PRC1 ZNF865 ZNF419 ZNF668 ASPH ZNF611	4.39e-06	423	244	18	int:NOTCH2
Interaction	LTBP2 interactions	ZNF765 ZNF497 ZNF555 CTC1 ZNF865 ZNF251 ASPH ZNF611	8.88e-06	85	244	8	int:LTBP2
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	ZNF765 ZNF845 ZNF527 ZNF586 ZNF154 ZNF155 ZNF460 RPS19 ZNF112 ZNF829 ZNF551 ZNF836 ZNF497 ZNF534 ZNF616 ZNF606 ZNF649 ZFP14 ZNF865 ZNF850 ZNF529 ZNF835 ZNF419 ZNF540 ZNF256 ZNF566 ZNF611 ZNF420	1.14e-10	1192	250	28	chr19q13
Cytoband	19q13.12	ZNF829 ZFP14 ZNF850 ZNF540 ZNF566 ZNF420	2.84e-06	72	250	6	19q13.12
Cytoband	19q13.43	ZNF586 ZNF551 ZNF497 ZNF835 ZNF419 ZNF256	8.58e-06	87	250	6	19q13.43
Cytoband	19q13.41	ZNF836 ZNF534 ZNF616 ZNF649 ZNF611	7.02e-05	78	250	5	19q13.41
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	SP1 ZNF765 BNC2 SP2 ZNF845 ZNF140 ZNF143 ZNF527 ZNF586 ZBTB17 ZNF154 ZNF155 ZFP3 ZNF658 ZNF460 ZNF177 ZNF189 ZNF112 BCL6 ZNF829 ZNF551 ZNF836 ZNF497 ZSCAN30 ZNF735 ZNF534 ZNF479 ZNF616 ZNF606 ZNF649 ZFP62 ZNF354A ZNF555 ZNF596 ZNF343 ZFP14 ZNF865 YY1 ZNF850 ZNF251 ZNF529 ZNF879 ZNF835 ZNF2 ZNF557 ZNF419 ZNF668 ZNF630 ZSCAN20 ZNF35 ZNF540 ZNF256 ZNF566 ZNF611 SP9 ZNF561 ZNF420 ZNF396 ZNF853 ZNF454 PRDM14	2.26e-39	718	186	61	28
GeneFamily	Zinc fingers C2H2-type\|Sp transcription factors	SP1 SP2 SP9	8.60e-05	9	186	3	755
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	MAP1B GRXCR1 SFI1 PPP1R26 SPOCD1 MARF1 TNS1 HYDIN	5.81e-04	181	186	8	694
GeneFamily	Dopamine receptors	DRD1 DRD2	1.03e-03	5	186	2	181
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP	ZFP3 ZNF460 GALNT16 ZFP62 LAMA4 ZNF850 ZNF557 JPH1 ZSCAN20 ZNF561 HAO2	1.30e-06	182	246	11	M4255
Coexpression	NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON	ZNF527 ZNF829 ZNF529 ZNF540 ZNF420	1.62e-06	22	246	5	M8692
Coexpression	GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	HELB PHF1 PLEC CTC1 DGKD ZNF419 ZNF540 MARF1 ERCC6L2 CCDC180	2.00e-05	199	246	10	M8606
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	GPHN ZNF658 SMC5 RBSN ZNF630 FAM222B ZNF256 ERCC6L2 TNS1	4.34e-07	166	250	9	f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BNC2 SFI1 HELB TAS2R30 MED17 CTC1 PCSK7 PRKCH SAMD3	1.81e-06	197	250	9	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BNC2 SFI1 HELB HERC1 GOLGB1 PCSK7 PRKCH SAMD3 VPS13B	1.96e-06	199	250	9	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	356C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ZNF155 MATN1 PMEPA1 PTPRS ZNF256 TTC39A PCDH9 PROC	4.21e-06	164	250	8	fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABHD15 DENND4A IRS1 SLC9A7 HERC1 MLXIPL MTOR DOP1A	6.51e-06	174	250	8	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	healthy_donor-Lymphocytic-Dendritic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ABHD15 PMEPA1 PTPRS ASPH RAB15 ST6GALNAC4 TTC39A PROC	1.06e-05	186	250	8	916f2aeea4989ba7a29e071e348a51010f010223
ToppCell	healthy_donor-Lymphocytic-Dendritic-pDC\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ABHD15 PMEPA1 PTPRS ASPH RAB15 ST6GALNAC4 TTC39A PROC	1.06e-05	186	250	8	45f66619e45d590c7365a51782d4ac46b7d31fde
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK5 ADAMTS9 CAPN2 LAMA3 DGKD TEAD1 ANKRD13A ASPH	1.14e-05	188	250	8	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	COVID-19_Severe-pDC\|World / disease group, cell group and cell class	ABHD15 HESX1 PTPRS SLC9A7 ASPH ST6GALNAC4 TTC39A PROC	1.14e-05	188	250	8	4c8e328b8206120708b05ea3c5865a0200dc5c4e
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAP1B DOCK5 ADAMTS9 HECW2 DOCK6 ADCY4 LAMA4 ARAP3	1.14e-05	188	250	8	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 PMEPA1 BMP7 DOCK10 DGKD CPLX3 SP9 GRIP2	1.19e-05	189	250	8	979b7fa947538aa7ca4a219263da2575869a2caa
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABHD15 PMEPA1 PTPRS SLC9A7 ASPH ST6GALNAC4 TTC39A PROC	1.24e-05	190	250	8	9a91bf1ea105029e6412d0d9060bca325299ce26
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABHD15 PMEPA1 PTPRS SLC9A7 ASPH ST6GALNAC4 TTC39A PROC	1.24e-05	190	250	8	2c1c079fd411c03bc3f383aa927eea9446716960
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABHD15 PMEPA1 PTPRS SLC9A7 ASPH ST6GALNAC4 TTC39A PROC	1.24e-05	190	250	8	a95aea3aa707fc4574810706341a5f32b3d00209
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	BCL6 ITGAM STX3 GCA PYGL MAP4K4 ARAP3 UNC80	1.28e-05	191	250	8	d4f77c73311d1149466bbfe4adbd6a301946ec90
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RPL26 BACH2 MTSS1 RPS19 PMEPA1 SLC9A7 NETO1 PCDH9	1.28e-05	191	250	8	b374676ac90572d65895052d46469906e2b6fd93
ToppCell	Healthy-pDC\|World / disease group, cell group and cell class	ABHD15 PMEPA1 PTPRS SLC9A7 ASPH ST6GALNAC4 TTC39A PROC	1.28e-05	191	250	8	6e1d825dc33b915b95f13ccd237a552160a4be98
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 PMEPA1 BMP7 DOCK10 DGKD CPLX3 SP9 GRIP2	1.33e-05	192	250	8	342842378c20267c5044bdd622515e8b9f895623
ToppCell	Healthy-pDC\|Healthy / disease group, cell group and cell class	ABHD15 PMEPA1 PTPRS SLC9A7 ASPH ST6GALNAC4 TTC39A PROC	1.33e-05	192	250	8	33d695a28d22b4af111df9591830a33bb7ef7b2d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 PMEPA1 BMP7 DOCK10 DGKD CPLX3 SP9 GRIP2	1.49e-05	195	250	8	98ca9f3aa36211dde1e6f7f3817b9418c95e583e
ToppCell	mild-pDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ABHD15 PMEPA1 HESX1 SLC9A7 ASPH ST6GALNAC4 TTC39A PROC	1.61e-05	197	250	8	0cb00daa6943f7a7fb34a8fdf51188646af65686
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP1B BCL6 ADAMTS9 PYGL PLEC SPOCD1 CAPN2 POM121C	1.73e-05	199	250	8	85bb28369e0568b7b3bda095722102fc793f60ef
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	MTSS1 PMEPA1 BMP7 DOCK10 DGKD CPLX3 SP9 GRIP2	1.79e-05	200	250	8	e90155498397524b812c46f2412320230b445bb6
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	MTSS1 PMEPA1 BMP7 DOCK10 DGKD CPLX3 SP9 GRIP2	1.79e-05	200	250	8	7345cc7dc24b9174541a3e68ecac8c4c092be400
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2--L1-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	MTSS1 PMEPA1 BMP7 DOCK10 DGKD CPLX3 SP9 GRIP2	1.79e-05	200	250	8	f268cb1bb047e88913a828614b0a77871f5f8814
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	MTSS1 PMEPA1 BMP7 DOCK10 DGKD CPLX3 SP9 GRIP2	1.79e-05	200	250	8	5ff9ac97ef970b3b74ebb07f62a0a1f4176a10b4
ToppCell	3'-GW_trimst-1-LargeIntestine-Epithelial-neuro-epithelial-Progenitor_(NEUROG3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MATN1 CHRND DLGAP3 MFNG NHLH1 GCA TTC39A	2.56e-05	153	250	7	20786807bba3bcd70ce744f8b6454e064199ed9f
ToppCell	356C-Myeloid-Dendritic-pDC\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	ZNF155 MATN1 PMEPA1 PTPRS TTC39A PCDH9 PROC	3.83e-05	163	250	7	ae9c5eb19657ea94b7f2357cbc8679acd697b8fe
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Lamp5-Cplx3_(Substantia_Innominata_(SI))-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ZNF143 RGSL1 MROH5 SBNO2 CPLX3	4.28e-05	69	250	5	3074ec10315fb21048215125ec08b0d7922da3d9
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Lamp5-Cplx3_(Substantia_Innominata_(SI))\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ZNF143 RGSL1 MROH5 SBNO2 CPLX3	4.28e-05	69	250	5	f731d4500b139a8bef5c9185368509bf5a3791db
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Lamp5-Cplx3_(Substantia_Innominata_(SI))--\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ZNF143 RGSL1 MROH5 SBNO2 CPLX3	4.28e-05	69	250	5	40eb84fe36da5a4a82bd9b2d962b829e2c97a059
ToppCell	NS-critical-d_0-4-Epithelial-unknown_epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ZNF460 BACH2 SPTBN5 BMP7 ZNF555 JPH1 ZNF419	4.31e-05	166	250	7	dd02bbe4af609c6348dc92417254f4740f2900a8
ToppCell	367C-Myeloid-Dendritic-pDC\|367C / Donor, Lineage, Cell class and subclass (all cells)	ABHD15 C15orf39 PTPRS SLC9A7 FYTTD1 ST6GALNAC4 PROC	4.47e-05	167	250	7	650de8cd5df070639b8aa292aacead739cfdb02c
ToppCell	mild_COVID-19_(asymptomatic)-pDC\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	PMEPA1 BMP7 PTPRS CC2D2A ST6GALNAC4 TTC39A PROC	4.65e-05	168	250	7	968405ea56f7d001ef83ff9274610923c3b2d55d
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-5\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BACH2 IRS1 DNAJC22 ZNF829 ZNF343 MLXIPL PCDH9	5.20e-05	171	250	7	23b3120706bb9c20b9214fe3760c6d7a84f1e749
ToppCell	AT1-AT2_cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	GPR87 ZNF112 PMEPA1 GALNT16 DDOST FAM222B PROC	5.20e-05	171	250	7	0b9912f07393aca889db72b40da08e0bc9bc1e8c
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BACH2 BCL6 SRGAP3 KIF23 DOCK10 C2CD3 MTOR	6.01e-05	175	250	7	bb058e714d21a0ec8532eaf3c7dd2faf78016bc0
ToppCell	CF-Lymphoid-pDC\|CF / Disease state, Lineage and Cell class	ABHD15 PMEPA1 HESX1 PTPRS ST6GALNAC4 TTC39A PROC	6.23e-05	176	250	7	dd1e529a9e413bcaab43584afbe059e1464ffb53
ToppCell	RV-11._Adipocyte\|World / Chamber and Cluster_Paper	PFKFB1 NWD2 PTPRS PYGL LAMA4 MLXIPL ASPH	6.46e-05	177	250	7	f0edf04930692418953e4f00a917257804ec0ffd
ToppCell	Severe-Lymphoid-pDC-\|Severe / Condition, Lineage, Cell class and cell subclass	ABHD15 PMEPA1 PTPRS SLC9A7 ST6GALNAC4 PCDH9 PROC	7.43e-05	181	250	7	277ce4c49121da0990a5933b19d2c6af9bbe253e
ToppCell	Severe-Lymphoid-pDC\|Severe / Condition, Lineage, Cell class and cell subclass	ABHD15 PMEPA1 PTPRS SLC9A7 ST6GALNAC4 PCDH9 PROC	7.43e-05	181	250	7	2caecb7c5dcdad46fd02b4ffb73cb613ce835187
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPHN MAP1B ADAMTS9 PTPRS LAMA3 ZNF35 ATOH8	7.43e-05	181	250	7	136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell	facs-Marrow-T-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABHD15 STX3 PTPRS SRGAP3 MAP4K4 CAPN2 DOCK10	7.43e-05	181	250	7	7286700396676fdc41d9723979b8b408177aceb9
ToppCell	3'-Adult-LargeIntestine-Epithelial-Tuft-related-Microfold_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGAM BMP7 TINAG SNX8 DDX60L PLEC DRD2	7.70e-05	182	250	7	b4f347fb684f6840c166d7473f3f56389f69c14b
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF586 CDC42EP4 ZNF460 ZNF177 DDOST ARGFX BSCL2	7.70e-05	182	250	7	209b455eaa135825fa6e6c71bf7d2072cebf11f2
ToppCell	Basal\|World / shred by cell class for mouse tongue	MAP1B WWC2 PTPRS PLEC LAMA3 LRRC8D TNS1	7.96e-05	183	250	7	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PMEPA1 BMP7 DOCK10 DGKD CPLX3 SP9 GRIP2	8.52e-05	185	250	7	6e7fefdd65d30abaffb26b92b0d04e1630d262ad
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BACH2 IRS1 ADAMTS9 SPOCD1 DGKD TACC2 TNS1	8.52e-05	185	250	7	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SP1 ITGAM SRGAP3 PKD1 DDX60L ZFP14 ZNF420	8.82e-05	186	250	7	74c238759c5d3fd39127ec0060d0c2cb16b326d4
ToppCell	control-Myeloid-pDC\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ABHD15 PMEPA1 PTPRS RAB15 ST6GALNAC4 TTC39A PROC	8.82e-05	186	250	7	fe31e9cf4575ee40b50489593c51d8c36c3cc532
ToppCell	PBMC-Severe-Myeloid-pDC-pDC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABHD15 HESX1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	8.82e-05	186	250	7	31df1eafa3010bc1be6fc4d4689f1393d69b6b13
ToppCell	PBMC-Severe-Myeloid-pDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ABHD15 HESX1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	8.82e-05	186	250	7	b95be984e308d4f9061274a35995ec558d434e74
ToppCell	PBMC-Severe-Myeloid-pDC-pDC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ABHD15 HESX1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	8.82e-05	186	250	7	8f7949740286f64e034d1eb533ebc2c6f71ae966
ToppCell	PBMC-Severe-Myeloid-pDC-pDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABHD15 HESX1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	8.82e-05	186	250	7	b70cd94c651b56dcf2e55554533a5f1130845390
ToppCell	COVID-19_Severe-Myeloid-pDC\|COVID-19_Severe / Disease group, lineage and cell class	ABHD15 HESX1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	8.82e-05	186	250	7	3db5ed69d49e5d79f990aca0295ddce4c297a05c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DENND4A BCL6 ADCY5 ADAMTS9 TNS1 HYDIN DNAH11	8.82e-05	186	250	7	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	PBMC-Severe-Myeloid-pDC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABHD15 HESX1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	8.82e-05	186	250	7	eaa431ccd4cdd36fe06a44987603ec9979025aa8
ToppCell	PBMC-Severe-Myeloid-pDC-pDC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ABHD15 HESX1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	8.82e-05	186	250	7	95c7318e521fb6aa02e244b1e81e6b2a62107756
ToppCell	CD8+_Memory_T_cell-FLU-0\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	RPL26 RPS19 SFI1 ZNF551 SEMA4A ZNF835 ZNF256	8.82e-05	186	250	7	b5edd4ec462c7cd87f567b8b6f86259ddbbf096d
ToppCell	control-Myeloid-pDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ABHD15 PMEPA1 PTPRS RAB15 ST6GALNAC4 TTC39A PROC	8.82e-05	186	250	7	fccee4cfcc887358cf916d974f29627095b5ad9c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BNC2 DENND4A BCL6 ADCY5 ADAMTS9 TNS1 HYDIN	9.12e-05	187	250	7	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MAP1B KDM5D PMEPA1 PTPRS ZNF343 ST6GALNAC4 PROC	9.12e-05	187	250	7	d3563bb087e476baea5b59389e4d34d0ff98cac5
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 PMEPA1 BMP7 DOCK10 DGKD SP9 GRIP2	9.42e-05	188	250	7	8268574584e5fb869a6cb8bbd7135cd7454a6a25
ToppCell	PBMC-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ABHD15 PMEPA1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	9.42e-05	188	250	7	89411c4db3df5e1dc36cf8af4ffcc0abbecbe4df
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 BCL6 PMEPA1 DOCK10 CPLX3 SP9 GRIP2	9.42e-05	188	250	7	433a25fe52914e07e7ba695881f9bcca2d9467ff
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic\|GI_large-bowel / Manually curated celltypes from each tissue	ZNF112 ITGAM TLR8 CC2D2A PYGL MLXIPL ATOH8	9.42e-05	188	250	7	d0045fdda757d191dabc7853f6a6e99c0e97d93d
ToppCell	PBMC-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ABHD15 PMEPA1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	9.42e-05	188	250	7	de6a270b6e4fe09c39a52c296632d86ada98465b
ToppCell	PBMC-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ABHD15 PMEPA1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	9.42e-05	188	250	7	879054b780378ae05be68e597c77c931bf0ade03
ToppCell	COVID-19_Severe-pDC\|COVID-19_Severe / Disease condition and Cell class	ABHD15 PMEPA1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	9.42e-05	188	250	7	475008f45673b42b75ef231c2df91f8b9adc9201
ToppCell	(0)_Myeloid-(011)_pDC\|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization)	ABHD15 PMEPA1 PTPRS RAB15 ST6GALNAC4 TTC39A PROC	9.42e-05	188	250	7	a81b5d840490d6a636fe168f8cff2c4984369f09
ToppCell	COVID-19_Severe-pDC-\|COVID-19_Severe / Disease condition and Cell class	ABHD15 PMEPA1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	9.42e-05	188	250	7	9fd1116e31a05554850b8ed3c005ea660dfbd51c
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes\|GI_large-bowel / Manually curated celltypes from each tissue	ZNF112 ITGAM TLR8 CC2D2A PYGL MLXIPL ATOH8	9.42e-05	188	250	7	0bcf04aa47738f43c1a87dae5dc487738ee86f8c
ToppCell	COPD-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	BACH2 ASPM TACC2 TEAD1 SNX25 PRKCH HYDIN	9.42e-05	188	250	7	186fe1ea328c942910190a4240262c0d8642ea3b
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	DOCK5 WWC2 LAMA3 TACC2 TEAD1 SNX25 ASPH	9.42e-05	188	250	7	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	PBMC-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABHD15 PMEPA1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	9.74e-05	189	250	7	a9ad1fb12304541f909dd0eeac9b9eb28c31fd41
ToppCell	COVID-19_Mild-Myeloid-pDC\|COVID-19_Mild / Disease group, lineage and cell class	ABHD15 PMEPA1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	9.74e-05	189	250	7	c6cfd6aa21c19f2c62d80218bbc924e14e82aada
ToppCell	Control-Myeloid-pDC\|Control / Disease group, lineage and cell class	ABHD15 PMEPA1 PTPRS ASPH ST6GALNAC4 TTC39A PROC	9.74e-05	189	250	7	46770b99da42f11f10cfc67cea8562342d60b867
ToppCell	PBMC-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABHD15 PMEPA1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	9.74e-05	189	250	7	98ca646231fbd5f29827c2dd31ac4503026bad7d
ToppCell	PBMC-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABHD15 PMEPA1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	9.74e-05	189	250	7	209cae68d78c8f72479b169e27c3ff7e143adece
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 PMEPA1 DOCK10 DGKD CPLX3 SP9 GRIP2	1.01e-04	190	250	7	3b8d1e66ae68c1eee64095e75195d76d97e24026
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 PMEPA1 DOCK10 DGKD CPLX3 SP9 GRIP2	1.01e-04	190	250	7	56cc761e50fddfb5366391518b4d8e16589b6b42
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ABHD15 PMEPA1 PTPRS ASPH ST6GALNAC4 TTC39A PROC	1.01e-04	190	250	7	39c8ddc2639bf3e986dae11fbae61a735614b604
ToppCell	Control-Lymphoid-NK\|Lymphoid / Disease state, Lineage and Cell class	BNC2 MTSS1 ITGAM DOCK5 DGKD PRKCH SAMD3	1.01e-04	190	250	7	1584c68b58c7f406d9b0e8451beea3e6f8980c56
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ABHD15 PMEPA1 PTPRS ASPH ST6GALNAC4 TTC39A PROC	1.01e-04	190	250	7	18dfa84c62dcf081ce9958a71e76a394ec0968e4
ToppCell	COVID-19_Severe-pDC\|COVID-19_Severe / disease group, cell group and cell class	ABHD15 PTPRS SLC9A7 ASPH ST6GALNAC4 TTC39A PROC	1.01e-04	190	250	7	c5ab6b7492fb86aff3d2af3eb671c9f985ae4aeb
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ABHD15 PMEPA1 PTPRS ASPH ST6GALNAC4 TTC39A PROC	1.01e-04	190	250	7	adffa93635da10251f28b2089fd96b189775c8b4
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 PMEPA1 DOCK10 DGKD CPLX3 SP9 GRIP2	1.01e-04	190	250	7	25d4b591f75c26e404a34c42f1742d580af6598d
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 PMEPA1 DOCK10 DGKD CPLX3 SP9 GRIP2	1.01e-04	190	250	7	be2b184a3559da41ba387ae0fdbeb9ae532868a5
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 PMEPA1 DOCK10 DGKD CPLX3 SP9 GRIP2	1.01e-04	190	250	7	dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9
ToppCell	COVID-19_Moderate-pDC\|World / disease group, cell group and cell class	ABHD15 PMEPA1 PTPRS SLC9A7 ST6GALNAC4 TTC39A PROC	1.04e-04	191	250	7	93adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9
ToppCell	(011)_pDC\|World / immune cells in Peripheral Blood (logTPM normalization)	ABHD15 PMEPA1 PTPRS RAB15 ST6GALNAC4 TTC39A PROC	1.04e-04	191	250	7	d82ac4f6d9863734e09bf3cb71c1354a49b66b4f
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_B0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	LEMD3 BTBD16 ZNF396 TNS1 EPB42 DNAH11	1.05e-04	133	250	6	386c9bbd9bab62209a67ebae6cd6ac0d7cef0a2d
ToppCell	proximal-Hematologic-Platelet/Megakaryocyte\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZNF527 ZFP3 ZNF658 SPTBN5 SLC9A7 ZSCAN20 ZNF396	1.07e-04	192	250	7	522d1bb15edf1d6006b80289bd3baadb99584ae8
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	DENND4A SFI1 HELB KMT2C HERC1 DOCK10 PRKCH	1.07e-04	192	250	7	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 PMEPA1 DOCK10 DGKD CPLX3 SP9 GRIP2	1.07e-04	192	250	7	f6ec683b2133b3095a1fcc06ca8605cf38f774b5
ToppCell	proximal-3-Hematologic-Platelet/Megakaryocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ZNF527 ZFP3 ZNF658 SPTBN5 SLC9A7 ZSCAN20 ZNF396	1.07e-04	192	250	7	f5f83dec37dff32a0c471cb05d23d13b0b0ad0c9
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 PMEPA1 DOCK10 DGKD CPLX3 SP9 GRIP2	1.07e-04	192	250	7	63d1b3efe93e5ff939278ebe40bacb38218ea09b
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 PMEPA1 DOCK10 DGKD CPLX3 SP9 GRIP2	1.07e-04	192	250	7	bd3fa6c8fcb618db64d11f25cabaf08608957c35
ToppCell	Control-B_intermediate-10\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MTSS1 TLR8 WWC2 KCNJ11 NETO1 PRKCH PCDH9	1.07e-04	192	250	7	224bd958369ba8fa0d7be2126f7dc61c9f6ac19d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTSS1 PMEPA1 DOCK10 DGKD CPLX3 SP9 GRIP2	1.07e-04	192	250	7	690b3d17c481159bc96b8bc7f6a66b51343ee858
Disease	autosomal dominant polycystic kidney disease (is_implicated_in)	PKD1 MTOR	3.69e-04	4	233	2	DOID:898 (is_implicated_in)
Disease	Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency	CHRND MUSK	3.69e-04	4	233	2	C1837092
Disease	ovarian serous carcinoma	BNC2 LAMA3 LAMA4 PRC1	4.77e-04	46	233	4	EFO_1001516
Disease	end stage renal disease (implicated_via_orthology)	IRS1 DRD1 MTOR	5.02e-04	20	233	3	DOID:783 (implicated_via_orthology)
Disease	heroin dependence (biomarker_via_orthology)	DRD1 DRD2	6.11e-04	5	233	2	DOID:9976 (biomarker_via_orthology)
Disease	apolipoprotein B measurement	SP1 BNC2 ABHD15 ZNF112 PMEPA1 SNX8 PISD PLEC DOCK6 MLXIPL PCSK7 HYDIN MUSK DNAH11	8.65e-04	663	233	14	EFO_0004615
Disease	Myasthenic Syndromes, Congenital	CHRND PLEC MUSK	8.70e-04	24	233	3	C0751882
Disease	traumatic brain injury (biomarker_via_orthology)	DRD1 DRD2 CAPN2	8.70e-04	24	233	3	DOID:0081292 (biomarker_via_orthology)
Disease	procollagen C-endopeptidase enhancer 1 measurement	MUSK DNAH11	9.12e-04	6	233	2	EFO_0801920
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	DOCK6 ATG16L2 JPH1 MLXIPL PCSK7 MUSK	1.40e-03	153	233	6	EFO_0004611, EFO_0020946
Disease	blindness (implicated_via_orthology)	RPL26 RPL26L1	1.68e-03	8	233	2	DOID:1432 (implicated_via_orthology)
Disease	diffuse large B-cell lymphoma (is_marker_for)	BCL6 DICER1	1.68e-03	8	233	2	DOID:0050745 (is_marker_for)
Disease	amnestic disorder (implicated_via_orthology)	IRS1 IRS4	2.15e-03	9	233	2	DOID:10914 (implicated_via_orthology)
Disease	Recurrent depression	DRD1 DRD2	2.15e-03	9	233	2	C0221480
Disease	Pituitary Adenoma	DRD2 DICER1	2.15e-03	9	233	2	C0032000
Disease	level of Phosphatidylcholine (16:0_22:4) in blood serum	MAP4K4 MUSK	2.15e-03	9	233	2	OBA_2045078
Disease	neuroimaging measurement	SP1 SPIRE2 MAP1B PMEPA1 LUZP1 PKD1 CC2D2A PLEC SZT2 CAPN2 TACC2 POM121C JPH1 MLXIPL TNS1 MUSK PROC DNAH11	2.20e-03	1069	233	18	EFO_0004346
Disease	cutaneous squamous cell carcinoma	BNC2 ZNF143 BACH2	2.23e-03	33	233	3	EFO_1001927
Disease	Malignant neoplasm of breast	GALNT16 CHRND SRGAP3 KCNJ1 SPOCD1 GOLGB1 TACC2 PRC1 ZNF668 SLC9A2 TXNDC15 ARAP3 TRMT2A MTOR TNS1 CDH10 VPS13B DOP1A	2.31e-03	1074	233	18	C0006142
Disease	metastasis measurement, disease progression measurement	YY1 ATOH8 SP9	2.43e-03	34	233	3	EFO_0007675, EFO_0008336
Disease	phosphatidylethanolamine ether measurement	GALNT16 MUSK	2.68e-03	10	233	2	EFO_0010229
Disease	cigarettes per day measurement	SPIRE2 PMEPA1 PHF1 DLGAP3 DRD2 COP1 POM121C MLXIPL ZNF668 PCDH9	2.68e-03	438	233	10	EFO_0006525
Disease	sleep duration, high density lipoprotein cholesterol measurement	PMEPA1 DOCK6 MLXIPL PCSK7 MUSK	2.78e-03	121	233	5	EFO_0004612, EFO_0005271
Disease	intellectual disability (implicated_via_orthology)	IRS1 KDM5D IRS4 CAPN2	2.97e-03	75	233	4	DOID:1059 (implicated_via_orthology)
Disease	Enzymopathy	GCLC KIF23	3.26e-03	11	233	2	C0520572
Disease	level of Sterol ester (27:1/20:5) in blood serum	NWD2 MUSK	3.26e-03	11	233	2	OBA_2045197
Disease	neutrophil count	SP1 BNC2 DENND4A BACH2 GALNT16 PKD1 SLC9A7 NHLH1 SEMA4A DOCK6 MAP4K4 PCDHA10 TEAD1 SBNO2 RIT1 ANKRD13A MLXIPL PRKDC STK38L HYDIN MUSK	3.29e-03	1382	233	21	EFO_0004833
Disease	metabolite measurement, body weight gain	TACC2 MUSK	3.89e-03	12	233	2	EFO_0004566, EFO_0004725
Disease	Oligospermia	DICER1 BSCL2	3.89e-03	12	233	2	C0028960
Disease	HMG CoA reductase inhibitor use measurement	PMEPA1 PLEC DOCK6 MLXIPL FAM222B DNAH11	4.01e-03	189	233	6	EFO_0009932
Disease	Hypertensive disease	ADCY5 GCLC KCNJ1 DRD2 MTOR PROC	4.11e-03	190	233	6	C0020538
Disease	allergic rhinitis	BACH2 BCL6 LAMA3 LAMA4 SMARCE1	4.17e-03	133	233	5	EFO_0005854
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	DOCK6 MUSK	4.57e-03	13	233	2	OBA_2045159
Disease	frontal theta oscillation measurement	GCLC YY1	4.57e-03	13	233	2	EFO_0004800
Disease	Autism Spectrum Disorders	CHD8 PCDH9 CDH10 UNC80	4.66e-03	85	233	4	C1510586
Disease	Waxy flexibility	DRD1 DRD2	6.09e-03	15	233	2	C0233612
Disease	Dyskinesia, Medication-Induced	DRD1 DRD2	6.09e-03	15	233	2	C0751088
Disease	Catalepsy	DRD1 DRD2	6.09e-03	15	233	2	C0007370
Disease	Dyskinesia, Drug-Induced	DRD1 DRD2	6.09e-03	15	233	2	C0013386
Disease	level of Triacylglycerol (53:3) in blood serum	MLXIPL MUSK	6.09e-03	15	233	2	OBA_2045165
Disease	Neurodevelopmental Disorders	ADCY5 KMT2C SRGAP3 WDR45	6.39e-03	93	233	4	C1535926
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	PKD1 MTOR	6.93e-03	16	233	2	DOID:0110861 (implicated_via_orthology)
Disease	body mass index, type 2 diabetes mellitus	ADCY5 MTOR	6.93e-03	16	233	2	EFO_0004340, MONDO_0005148
Disease	mean corpuscular hemoglobin concentration	SP1 DENND4A BACH2 SLC30A1 HECW2 CC2D2A MED17 GOLGB1 ENTHD1 MLXIPL SLC9A2 FAM222B RPS19BP1 PRKDC ZNF853 MUSK VPS13B	7.02e-03	1105	233	17	EFO_0004528
Disease	omega-6:omega-3 polyunsaturated fatty acid ratio	MLXIPL ASPH MUSK	7.25e-03	50	233	3	EFO_0010732
Disease	platelet component distribution width	MTSS1 IRS1 SLC30A1 ADCY5 DOCK5 MLH1 PLEC HERC1 IQCE DOCK10 MLXIPL DENND2C MUSK	7.34e-03	755	233	13	EFO_0007984
Disease	response to trauma exposure	PHTF2 SAMD3 DNAH11	7.66e-03	51	233	3	EFO_0008483

Protein segments in the cluster

Peptide	Gene	Start	Entry
SKRFTLRSHSARQNS	nan	466	A8MVM7
SLKRAFQTAHRVIAS	C2orf16	1356	Q68DN1
RRARLAHLKSSSTRA	CEP295NL	546	Q96MC4
AHLKSSSTRAQERER	CEP295NL	551	Q96MC4
STLASRRKRLTAHFE	COP1	351	Q8NHY2
TRERRSLILQFAKEH	PFKFB1	136	P16118
HHTKALSSRRLFVRR	EPB42	21	P16452
FEKQSERHGLARRLT	CHRND	401	Q07001
FIHDVRRRSKNRIAA	BACH2	646	Q9BYV9
RRKVAESHLPATFSR	BTNL10	231	A8MVZ5
IDTPRVRKQTRHFST	CHD8	1396	Q9HCK8
KLTRHQAVTGSRDRT	ATG16L2	431	Q8NAA4
VVLRRHSSSDLARQK	ARAP3	1331	Q8WWN8
GTRSLQKVRRVHFAN	CXorf58	16	Q96LI9
RVHFSQLEKRVSRSH	CTC1	966	Q2NKJ3
THKARLERRVTGSTN	BTBD16	6	Q32M84
FSKHNRTRCISRTEI	BNC2	691	Q6ZN30
TAAHAFKVAARATLR	CASR	876	P41180
LSTFIHAEDFARRRK	GPR15	341	P49685
RALTDFFRKRDHLQQ	GCA	186	P28676
ASRVAATTAIRRRHK	ARGFX	66	A6NJG6
RRRHQSEKANLTILF	DNAH11	2336	Q96DT5
ALSSLHSRRRLDTEK	ADCY4	206	Q8NFM4
RDLHINKSSSFVRSF	DOP1A	941	Q5JWR5
VTHRLAIDKRFRVFT	ATAD2	996	Q6PL18
LSLKRRSDRQQFLGH	ASPH	421	Q12797
IGQRTISTASRRHFK	COX7A2	11	P14406
AAVIRFRHLRSKVTN	DRD1	46	P21728
ARSIDRLRSEHVRKF	ADCY5	726	O95622
VHSLAATRKRAAERS	CCDC180	71	Q9P1Z9
RKFRAHETNLLIATS	DICER1	506	Q9UPY3
VHFRSIRSTGSKQRS	BMP7	286	P18075
RNRAASVIQKAVRHF	ASPM	3181	Q8IZT6
HLRVNLKFLTRTRST	RPS19BP1	71	Q86WX3
TEERIKGLSRHRASF	ABHD15	421	Q6UXT9
FHNEARSTLLRTVKS	GALNT16	131	Q8N428
SKRRVRTTFTTEQLH	ISX	81	Q2M1V0
FRAKHNERFISAVLS	NWD2	1226	Q9ULI1
LQAFLRSRDRSHQKF	DENND4A	601	Q7Z401
SFTRLTELVLQAHRK	RAB15	161	P59190
TSHRLSRHDKAVQRF	NETO1	501	Q8TDF5
QFRVASLHTRTRSLD	RBSN	536	Q9H1K0
DTFRVKRPHLRRSAS	IQCE	116	Q6IPM2
EATTRARATRKSLLH	AFMID	51	Q63HM1
RASHSAVDITKVARR	GPHN	301	Q9NQX3
FRRHFKSSSIQRSAA	HNRNPDL	86	O14979
SSRQVLKDDSLSRHR	LEMD3	271	Q9Y2U8
ARTSAHFARLRDFIK	ANKRD13A	386	Q8IZ07
FIDRHKQLRATARAT	CACNG2	201	Q9Y698
TRVHTISAAFEALRK	ATOH8	241	Q96SQ7
TRNHSLREKIQFIRT	HECW2	1106	Q9P2P5
DSLQRRHTSRKLRDF	FAM47C	841	Q5HY64
RTRQRTSHSILFSKR	ENTHD1	146	Q8IYW4
AREVEDRFRKTNHSS	MAP4K4	566	O95819
ALFKSHTQESRARVI	KLHL34	56	Q8N239
TFERGHKIIISSSRR	KMT2C	4861	Q8NEZ4
RAHVSKAALLQAVRR	MATN1	96	P21941
DQELKLFVSRHSARF	MAP1B	76	P46821
SHTLREFTKATNIRL	LAMA3	246	Q16787
DRPRKVRFRIASSHS	GRXCR1	11	A8MXD5
VRFRIASSHSGRVLK	GRXCR1	16	A8MXD5
RKFILAALSASHRNV	HECA	381	Q9UBI9
VARLDLSHNRLSFIK	LRIG3	76	Q6UXM1
RGRSAVTRRHKFDLA	HERC1	2871	Q15751
KFEHQGSRTRSRALE	KDM5D	1426	Q9BY66
RTKVEIANSRTAHAR	JPH1	371	Q9HDC5
RTTRRHFLRQEKSVI	DDX60L	416	Q5H9U9
TAQAHRRAETLIFSK	KCNJ11	171	Q14654
SEQRLLRRAKRSVHF	PCSK7	131	Q16549
HRSIEAKLRQFSSAL	MTSS1	86	O43312
FVTVLVRCRHASRFK	PCDH9	831	Q9HC56
RKHVRRTVNGLDTSA	FAM222B	71	Q8WU58
SERRIFNSFLHTALK	HERC4	581	Q5GLZ8
FSTLTRNIRHRRGEK	GCLC	186	P48506
FQNRRAKLKRSHRES	HESX1	156	Q9UBX0
QRAKRFHFRSEVNLA	NCBP3	91	Q53F19
SPSDLVRRARSKVFH	LHX1	71	P48742
VRRARSKVFHLNCFT	LHX1	76	P48742
KHIFLRSRAAATIDS	MED17	436	Q9NVC6
DLDNRFRKRTHSAGT	IRS1	516	P35568
FHKNREDRAALLRTF	OAZ1	176	P54368
VRETHSLFFRSLKDR	DDOST	56	P39656
KQFRVLFLSTVRTRH	HELZ	986	P42694
KERVALSHSSRRQRQ	NPTXR	251	O95502
SSRQFISQSSRKRKH	GPR87	236	Q9BY21
LTEKTALHLRARRNF	MVP	221	Q14764
KLSARSFISRHSQGR	PMEPA1	66	Q969W9
RLANSKAHTSRFISA	PTPRS	1686	Q13332
AELVQRLFRVASKRH	PCDHA10	56	Q9Y5I2
SFVQKARHRRTLFAS	POM121C	81	A8CG34
KRANSFLEELRHSSL	PROC	41	P04070
VGRSSAHRRLFRLKD	OTOP1	111	Q7RTM1
QFTQRKAERATLRSH	CPLX3	61	Q8WVH0
RLAHYSKRSTISSRE	H2BC1	81	Q96A08
NVHFKRTRRSINSAT	ADAMTS9	66	Q9P2N4
RATAKYRTAHATRER	NHLH1	71	Q02575
EHLSVLSRTFANQRR	HYDIN	376	Q4G0P3
VAHSSKLDRNRARRL	BNIP5	586	P0C671
SDQELNRSKRFRLLH	CC2D2A	901	Q9P2K1
NRSKRFRLLHLRSQE	CC2D2A	906	Q9P2K1
STQIRAFSRNRFKDH	C2CD3	361	Q4AC94
AALSSHRARSRSNKA	C2CD3	1971	Q4AC94
RANHSVARFLKRCFT	DOCK10	1051	Q96BY6
NFSHLVDRSTAIARK	DOCK5	416	Q9H7D0
RRAFAHKINRTVAAE	DOCK6	6	Q96HP0
RILTRKNGFNRHEIS	CDH10	546	Q9Y6N8
SQHRKQRRSRTAFTA	DMBX1	66	Q8NFW5
RLLAAKRAASFRHSS	DLGAP3	946	O95886
SENILRFSKFRVHES	HYAL4	271	Q2M3T9
QLVSSSVHSKRRSRA	CDC42EP4	6	Q9H3Q1
LHSVNSFARRLFIDK	ADGRF2	266	Q8IZF7
VFQREPFRKSHTSRS	DENND2C	846	Q68D51
RFSEEASLKRHTLQT	BCL6	526	P41182
ASSRHLRFKLQSLSR	LUZP1	11	Q86V48
DDKLRQSLRRFANTH	MARF1	426	Q9Y4F3
RLLTLTHRAQVKRFT	MARF1	1166	Q9Y4F3
VHKNRAQTLTRDRAF	DGKD	931	Q16760
KRVNTKRSSRAFRAH	DRD2	221	P14416
FSKQSHRPRTIRDRT	ERCC6L2	1066	Q5T890
RQRRREHKSSLSLAS	GRIP2	426	Q9C0E4
HRFSLQVNIRKRDNS	BSCL2	266	Q96G97
IHLSKNFFLTNRARE	CAPN2	446	P17655
SVAASITAQRHRRYK	DNAJC22	156	Q8N4W6
AARLEKVHSLFRRQL	SART3	241	Q15020
NLRETLRTFHKETGR	HELB	161	Q8NG08
VFIAVKTTRAFHRLR	MFNG	56	O00587
KVEQTAFSFLRDHLR	LRRC8D	526	Q7L1W4
KQELHSRAFLAITRS	PKD1	3706	P98161
AKSQFSIRLRTRSSH	LAMA4	1491	Q16363
KRRIANTHLNRESSR	KIF23	286	Q02241
RESSRSHSVFNIKLV	KIF23	296	Q02241
FVTSDRSKNRKRHFN	RPL26L1	6	Q9UNX3
RKFRHSVRAAAAAAA	IRS4	116	O14654
INRVRDKLTGRDFSH	MTOR	2501	P42345
EISSRHKFRLFQTLE	MROH5	136	Q6ZUA9
RSSRLLSALNSHKDR	PHF1	301	O43189
LRHARRAQIRKTSAS	RTL6	181	Q6ICC9
VKDRSLRLHRFTRGA	TAS2R30	301	P59541
RSLTQFKEEFRRLHL	SZT2	1751	Q5T011
LSARATRFHRETLEK	SFI1	506	A8K8P3
TRFHRETLEKQVFSL	SFI1	511	A8K8P3
NRFISSRQHKREFIG	RGSL1	501	A5PLK6
LTSARRARKSEVPHF	PHTF2	591	Q8N3S3
HESLRLQFLERFKSS	SRPRB	121	Q9Y5M8
FRSAAERDKALRVLH	TRMT2A	116	Q8IZ69
HFSRGSKSVARRVLQ	RPS19	91	P39019
RRSQHARKETEFLRL	STK38L	66	Q9Y2H1
SFHKLRDRAERIASR	SNX8	231	Q9Y5X2
KRFTASSILRTHIRQ	PRDM14	496	Q9GZV8
TATARFQRNHRLISE	SMARCE1	191	Q969G3
RTGRHKSVRRIFLFE	PLEKHG4	936	Q58EX7
RRLSEFQNLHRKLSE	SNX25	551	Q9H3E2
HRRGQTRKSLADIRF	SAMD3	251	Q8N6K7
AHAREQLSKSTRDFI	HAO2	11	Q9NYQ3
FRQHVTTLRETKASR	PRC1	156	O43663
FFERLHTSRVARVCK	SEMA4A	256	Q9H3S1
NTKNLLHRQTAFRDR	SLC3A1	651	Q07837
ALDSLRRKFHRVTAE	SBNO2	1106	Q9Y2G9
TRKAQAGLSLHDRRS	PPP1R26	1146	Q5T8A7
VHIFALKDTRLNRRS	WDR45	261	Q9Y484
HSRAVFNETKNSTRR	ITGAM	686	P11215
RFTRSDELQRHKRTH	SP1	666	P08047
FINHRLVESTSLRKA	MLH1	261	P40692
RITHISAEQKRRFNI	MLXIPL	651	Q9NP71
RAVLRSRLSSNKDHQ	OR6J1	316	Q8NGC5
ADLRIRKSQHSVLSR	STX3	111	Q13277
KRFTRSDELQRHLRT	SP9	371	P0CG40
TLARRFQHKAALRES	SPTBN5	426	Q9NRC6
AKLLSQLQRFDRTHR	C15orf39	816	Q6ZRI6
EAFSFKSNLERHRRI	ZNF845	446	Q96IR2
NHQKDTRQATFLFRR	FYTTD1	181	Q96QD9
KAFAVSSRLSRHERI	ZNF561	456	Q8N587
SFQRHIRKRRSTDFE	TLR8	446	Q9NR97
KAFRQRSSLTVHQRT	ZNF35	481	P13682
KSFSRSSFLIEHQRI	ZNF189	351	O75820
KSFSRSSFLIEHQRI	ZNF189	491	O75820
RSFAENSSLIKHLRV	ZNF586	241	Q9NXT0
RSAHRFITEKAVFSR	ST6GALNAC4	271	Q9H4F1
RSFKDRSTLIRHHRI	ZNF343	276	Q6P1L6
KAFSRSVDLRIHQRI	ZNF540	586	Q8NDQ6
KAFRGSSELRQHQRL	ZNF497	421	Q6ZNH5
FVRKSELLSHRRTHT	ZNF497	451	Q6ZNH5
KDFNRRSHLTRHQRT	ZNF460	231	Q14592
KRFAQSSSLAEHRRL	ZNF865	911	P0CJ78
RSFTTSNIRKVHVRT	ZNF143	336	P52747
KAFFDRSSLTVHQRI	ZNF2	236	Q9BSG1
QAFRRSSTLTNHKRI	ZNF735	276	P0CB33
KVFSQCSRLTVHRRI	ZNF616	556	Q08AN1
KAFNCSSSLRRHVRI	ZNF555	571	Q8NEP9
KAFNHSSVLRRHERT	ZNF596	426	Q8TC21
KERSSLSSRQHPFVR	WWC2	981	Q6AWC2
KAFSLSSDLVRHQRI	ZSCAN30	336	Q86W11
KSFSARAVSRSHQRA	UNC80	1716	Q8N2C7
RAFAERASLTKHSRV	ZNF668	371	Q96K58
FVVSSSLRKHERTHR	ZNF668	401	Q96K58
KAFRNSSCLRVHVRT	ZNF177	431	Q13360
KFFRDRSNLITHQRI	ZSCAN20	966	P17040
RKINFDHSLIRQSRS	PJVK	136	Q0ZLH3
DHSLIRQSRSSRKAV	PJVK	141	Q0ZLH3
SITDRRSFHEVREFK	RIT1	101	Q92963
AERFSSKIRSSREHQ	SRGAP3	71	O43295
RHSLRESIRKDSSLN	SLC9A2	641	Q9UBY0
FRKTSLLRAHVRLHT	SP2	536	Q02086
KRDRSFSEHDLAQLR	SPIRE2	436	Q8WWL2
NRSSADLRIRKTQHS	STX1B	106	P61266
FVTSDRSKNRKRHFN	RPL26	6	P61254
IKRFRARAQLVSGHS	SPOCD1	876	Q6ZMY3
FRTDARKIHTAPART	PISD	46	Q9UG56
GKRFSLDFNLRTHVR	YY1	361	P25490
KFFSQSSSLIRHRRS	ZNF256	526	Q9Y2P7
ITLTDNQRKLFFRRH	TNS1	1646	Q9HBL0
RFNHTDRTLETLKIF	TXNDC15	276	Q96J42
SFSRKSNLIRHRRVH	ZNF551	651	Q7Z340
FSRIAFLARHRKVHT	ZNF534	376	Q76KX8
RQIALASRSHQDAKR	TACC2	2696	O95359
KARLRSLESLHSFVA	PLEC	746	Q15149
HSFDGLRRKVSAQRL	PLEC	2781	Q15149
KSFSRGSLVTRHQRI	ZNF829	191	Q3KNS6
ALALSRARSTNVHSK	MYO18B	2171	Q8IUG5
DSLLFAHKRSERLQR	PRKDC	2676	P78527
RAFSRKSPFTVHQRV	ZNF630	326	Q2M218
QAFRRSSALTNHKRI	ZNF479	276	Q96JC4
FFQKTRLSTHRRIHT	ZNF658	751	Q5TYW1
KRFSVSSNLLRHRRT	ZNF853	576	P0CG23
KGFSQSSRLEAHRRV	ZNF112	756	Q9UJU3
RGFNRVDNLRSHVKT	ZBTB17	621	Q13105
KAFSRSSSLIQHERI	ZNF251	356	Q9BRH9
VRHKLTSRNERRSFH	VPS13B	1461	Q7Z7G8
TSRNERRSFHKLSEG	VPS13B	1466	Q7Z7G8
KAFTSISRLSRHHRI	ZNF879	351	B4DU55
DKAFSRSFSLILHQR	ZNF140	391	P52738
KAFRSGSDLTRHQRI	ZNF566	346	Q969W8
AKAFRFSSALIRHQR	ZNF835	256	Q9Y2P0
GTFRSSSSLRVHKRI	ZFP62	176	Q8NB50
FSRRSALNVHRKLHT	ZNF155	241	Q12901
KAFRDNSSFARHRKI	ZNF454	391	Q8N9F8
KAFNRGSLLTRHQRI	ZNF420	426	Q8TAQ5
EAFSFKSNLERHRRI	ZNF765	501	Q7L2R6
DKAFVRNSLLSRHTR	ZNF611	656	Q8N823
ECRKTFIRRSTLSQH	ZFP14	176	Q9HCL3
KSFRQSSSLIQHRRV	ZNF154	196	Q13106
GKTFRQSSSRIAHQR	ZNF354A	556	O60765
KVFRNSSSLTRHQRI	ZNF529	401	Q6P280
SSHIQVLARRKSRDF	TEAD1	91	P28347
TRNHTVLQGTRFKRA	TINAG	36	Q9UJW2
VAERFARRTHATQKN	SLC30A1	56	Q9Y6M5
SDERFFLISSKRSNH	TRIM64	371	A6NGJ6
KAFSRSAILIQHRRT	ZNF396	286	Q96N95
RSRTKQLFEVLHFLA	SLC9A7	406	Q96T83
SARAQRSKALLHLRN	TTC27	526	Q6P3X3
FRTQSIFTRHKRVHT	ZNF557	266	Q8N988
IRIRVKFRSSTQLHE	SMC5	971	Q8IY18
GRLFRENSSLVKHQR	ZNF419	461	Q96HQ0
LHFTLVKDRNVATTR	PYGL	36	P06737
SDERFFLISSKRSNH	TRIM64B	371	A6NI03
LCQRHRRKSSVTDSF	TTC39A	91	Q5SRH9
KSFAFRSAIIQHRRI	ZNF850	876	A8MQ14
KIFRQNSDLVNHRRS	ZNF836	281	Q6ZNA1
VFRNRSALTKHERTH	ZNF606	436	Q8WXB4
QAFRRSSTLTNHKRI	ZNF722	276	A0A1W2PQL4
KTFGTNSSLRRHLRI	ZFP3	176	Q96NJ6
FFQKTRLSTHRRIHT	ZNF658B	511	Q4V348
GRAFSRKSLLVVHQR	ZNF649	296	Q9BS31
KAFSRRIALTLHQRI	ZNF527	421	Q8NB42
VHRLSALFSSSQKRI	GOLGB1	2641	Q14789
RFFGHSRQRARLVSK	KCNJ1	31	P48048
TEATLQRDRIFKHFT	PRKCH	141	P24723
LSERKFVHRDLATRN	MUSK	716	O15146